REGMF
Price:
$12.05
Market Cap:
$63.35B
RemeGen Co., Ltd., a biopharmaceutical firm established in Yantai, People's Republic of China, in 2008, focuses on the discovery, development, and commercialization of biologics. The company aims to address unmet medical needs in autoimmune, oncology, and ophthalmic diseases across Mainland China and the United States. Its commercial portfolio includes Telitacicept (RC18), indicated for the autoimmune condition systemic lupus erythematosus, and Disitamab Vedotin (RC48), prescribed for various forms of cancer. RemeGen boasts a robust development pipeline. Telitacicept (RC18) is currently in Phase III clinical trials for neuromyelitis optica spectrum disorder and rheumatoid arthritis, and in P...[Read more]
Industry
Biotechnology
IPO Date
2021-01-21
Stock Exchange
OTC
Ticker
REGMF
According to RemeGen Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 63.42. This represents a change of -281.24% compared to the average of -34.99 of the last 4 quarters.
The mean historical PE Ratio of RemeGen Co., Ltd. over the last ten years is 1.16. The current 63.42 PE Ratio has changed 546.19% with respect to the historical average. Over the past ten years (40 quarters), REGMF's PE Ratio was at its highest in in the March 2026 quarter at 54.56. The PE Ratio was at its lowest in in the September 2025 quarter at -162.33.
Average
1.16
Median
-16.41
Minimum
-41.22
Maximum
71.65
Discovering the peaks and valleys of RemeGen Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 71.65
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -41.22
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 60.30 | -646.75% |
| 2024 | -11.03 | -49.37% |
| 2023 | -21.78 | -47.15% |
| 2022 | -41.22 | -157.53% |
| 2021 | 71.65 | -400.00% |
| 2020 | -23.88 | -3.51% |
| 2019 | -24.75 | -Infinity% |
The current PE Ratio of RemeGen Co., Ltd. (REGMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
9.16
5-year avg
11.58
10-year avg
1.16
RemeGen Co., Ltd.’s PE Ratio is greater than Abivax S.A. (-17.61), greater than 3SBio Inc. (4.11), greater than Shanghai Junshi Biosciences Co., Ltd. (-46.29), greater than Zealand Pharma A/S (3.10), greater than Sinopharm Group Co. Ltd. (6.17), greater than Kyowa Kirin Co., Ltd. (18.22), greater than Genscript Biotech Corporation (-5.97), greater than Ypsomed Holding AG (15.71), greater than MatsukiyoCocokara & Co. (16.67), greater than Sinopharm Group Co. Ltd. (6.17),
| Company | PE Ratio | Market cap |
|---|---|---|
| -17.61 | $8.08B | |
| 4.11 | $5.50B | |
| -46.29 | $4.84B | |
| 3.10 | $3.16B | |
| 6.17 | $6.73B | |
| 18.22 | $7.55B | |
| -5.97 | $3.50B | |
| 15.71 | $4.67B | |
| 16.67 | $5.74B | |
| 6.17 | $7.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RemeGen Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is RemeGen Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for RemeGen Co., Ltd. (REGMF)?
What is the highest PE Ratio for RemeGen Co., Ltd. (REGMF)?
What is the 3-year average PE Ratio for RemeGen Co., Ltd. (REGMF)?
What is the 5-year average PE Ratio for RemeGen Co., Ltd. (REGMF)?
How does the current PE Ratio for RemeGen Co., Ltd. (REGMF) compare to its historical average?